CML is a clonal myeloproliferative disorder of pluripotent stem cells driven by a reciprocal 1 7 translocation between chromosome 9 and 22, forming a BCR-ABL fusion gene. Tyrosine 1 8 kinase inhibitor drugs like imatinib are mainstay of treatment and cases resistant to these 1 9 3 1 in Hematological neoplasms like CML and should pave way for further research in this 3 2 direction.
Lipofectamine LTX (cat#15338100, Thermo-Fisher Scientific, MA, US) was used for the 1 0 3 co-transfection of the two plasmids, pC016I and pC034 using the manufacturer's protocol in 1 0 4 a six well plate containing approximately 50,00,00 cells from overnight culture of K562 1 0 5 cells in RPMI-1640 medium with 1% Penicillin-Streptomycin at a confluency of 75-80%. The cells were incubated overnight at 37°C with 5% CO 2 . After the overnight incubation, 1 0 7 old media was replaced with fresh and additionally 6 µg/mL of blasticidin antibiotic was 1 0 8 added as the positive selection marker for the plasmid in both test and negative control cells Total RNA was extracted using RNeasy kit from QIAGEN (cat#74104) as per the 1 1 5 manufacturer's protocol. A fraction of RNA was reverse transcribed to cDNA using 1 1 6
RevertAid first strand cDNA synthesis kit by Thermo Fisher scientific (cat#K1622) using 1 1 7 the manufacturer's protocol. The BCR-ABL cDNA region was amplified using specific 1 1 8 primers, forward 5'-ACAGAATTCCGCTGACCATCAATAAG-3', reverse 5'- 1634 cells were compared in the same software.
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The study was duly approved by the Institute's Ethics Committee and the Departmental content of 39% and no predicted off targets was chosen. found to be synchronous with the flow cytometry data after normalization with a significant 1 8 0 p-value of 0.01 (figure 2 C). sequencing data with BCR-ABL cDNA, we found 61.70% of total 47 aligned reads with 1 9 2 altered bases in the 28-nucleotide long crRNA region (supplementary figure S1). On 1 9 3 translation of these changes, we found sixteen candidate amino acid changes. Among these, EditR were found in NGS data too. One of these three has a very high effect on stability of after accounting for synonymous variants was calculated to be 57.45% forged, these cases then either require a complex treatment regime including trials with 2 0 7 other TKI drugs or ultimately a stem cell transplantation (SCT) 27 . SCT has its own set of CML with a RNA CRISPR since the p210 transcript wouldn't be likely affected by the 2 3 0 differences in intronic breakpoints. Working on this hypothesis, we designed this study to of CRISPR which targets RNA rather than the DNA and has been shown to have an 2 3 4 efficiency of around 50% 11 . In the current study too, we found the efficiency to be around 2 3 5 57.45%. This RNA targeting CRISPR system was able to lower the expression of 2 3 6
downstream genes of CML pathogenesis as per the KEGG 32 pathway ID hsa05220. Numbers after 'K562-1634-' denote passage numbers. Comparative western blot data for pCRK and pCRKL expression levels. K-K562 cells
